Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000008964 | SCV000456194 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Eurofins Ntd Llc |
RCV000729912 | SCV000857611 | uncertain significance | not provided | 2017-11-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002490341 | SCV002775288 | uncertain significance | Autosomal recessive nonsyndromic hearing loss 4; Pendred syndrome | 2022-04-04 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000729912 | SCV004227157 | uncertain significance | not provided | 2022-01-19 | criteria provided, single submitter | clinical testing | PM2_supporting |
Breakthrough Genomics, |
RCV000729912 | SCV005188729 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000008964 | SCV000029176 | pathogenic | Autosomal recessive nonsyndromic hearing loss 4 | 2007-06-01 | no assertion criteria provided | literature only |